Brad Hirakawa

Toxicologist (DABT) | Drug Discovery & Development

San Diego, California, United States

About

Experience

  • Associate Director, Toxicology at ADARx Pharmaceuticals Inc.
    Jul 2026 - Present · 1 mo

  • Aardvark Therapeutics (3 yrs)
    • Director / Head of Drug Safety Strategy and Operations
      Aug 2024 - Jun 2026 · 1 yr 11 mos

    • Consultant, Nonclinical Toxicologist
      Jul 2023 - Aug 2024 · 1 yr 2 mos

  • Pfizer (18 yrs)
    • Principal Scientist, Drug Safety R&D
      Mar 2018 - Apr 2023 · 5 yrs 2 mos

    • Senior Scientist, Drug Safety R&D
      Mar 2008 - Mar 2018 · 10 yrs 1 mo

    • Scientist, Drug Safety R&D
      May 2005 - Mar 2008 · 2 yrs 11 mos

  • Associate Scientist at Idun Pharmaceuticals (Acquired by Pfizer)
    Jul 2003 - May 2005 · 1 yr 11 mos

  • Graduate Student Intern, Drug Safety R&D at Pfizer
    Jun 2002 - Jul 2003 · 1 yr 2 mos